Abstract
Peptides and peptidomimetics are strongly re-emerging as amenable candidates in the development of therapeutic strategies against a multitude of pathologies. Unlike small organic compounds, peptides exhibit a high degree of specificity avoiding off-target side effects and a relatively low degree of toxicity. In this context, a successful strategy for the design and optimization of peptide…